This bill expands access to experimental treatments for patients with life-threatening or severely debilitating diseases by allowing them to try investigative drugs and treatments—including personalized treatments based on their genetic makeup—if they've exhausted FDA-approved options and their doctor recommends it. The law creates new eligibility requirements and protections, including informed consent and physician attestation, while removing previous restrictions on who can receive these experimental treatments. This is sometimes called "right to try" legislation, giving terminally ill patients another potential avenue when standard treatments have failed.
Signed by the Governor H.J. 554
Delivered to the Governor H.J. 528
Signed by the President S.J. 512
Signed by the Speaker H.J. 510
Senate Do Pass Passed, YEAS 34, NAYS 0. S.J. 471
Health and Human Services Certified uncontested, placed on consent
Health and Human Services Do Pass Passed, YEAS 7, NAYS 0.
Health and Human Services Scheduled for hearing
First read in Senate and referred to Senate Health and Human Services S.J. 267
House of Representatives Do Pass Passed, YEAS 68, NAYS 0. H.J. 269
Health and Human Services Certified uncontested, placed on consent
Health and Human Services Do Pass Passed, YEAS 13, NAYS 0.
Health and Human Services Scheduled for hearing
House of Representatives Referred to House Health and Human Services H.J. 171
First Reading House H.J. 154
Prime sponsor · Rep
R
Dist. HD-010
Do Pass
Health and Human Services — Do Pass
Do Pass
Health and Human Services — Do Pass